School of Public Health, Mount Kenya University, Thika, Kenya.
School of Applied Sciences, Mount Kenya University, Thika, Kenya.
Pan Afr Med J. 2024 May 28;48:22. doi: 10.11604/pamj.2024.48.22.42196. eCollection 2024.
intermittent preventive treatment remains a core strategy for malaria prevention in pregnancy. Sulfadoxine-pyrimethamine is recommended for all pregnant women in malaria-prone zones. It is scheduled monthly at each antenatal care visit for up to 36 weeks. Here, we sought to assess the knowledge, attitude, and practices of intermittent preventive treatment among pregnant women with malaria in Webuye Hospital.
a total of 140 participants aged between 18 and 49 years and at approximately 16 weeks of gestation were enrolled in this study, which utilized a mixed qualitative-quantitative method. Before enrollment, malaria testing was conducted using microscopy, and participants were divided into two cohorts: malaria-positive and malaria-negative. Close-ended and open-ended questionnaires were used. Qualitative-quantitative data analyses were performed.
our analysis revealed a significant difference between the proportion of mothers in the negative and positive groups in terms of their knowledge about side effects (p ≤ 0.001) and different doses (p ≤ 0.012) of intermittent preventive treatment. The proportion of mothers who knew side effects and different doses was higher among the malaria-positive group as compared to malaria-negative group with 37(52.9%, n=70) versus 18(25.7%, n=70) and 14(20.0%, n=70) versus 4(5.7%, n=70) respectively. Additionally, there was also a significant difference in knowledge about intermittent preventive treatment before administration (p ≤ 0.003) between the two groups.
good knowledge, attitude and practices on intermittent preventive treatment (IPT) benefits, side effects, safety, doses and other prior information should be leveraged to empower pregnant women in malaria-endemic zones.
间歇性预防治疗仍然是预防妊娠疟疾的核心策略。在疟疾流行地区,建议所有孕妇使用磺胺多辛-乙胺嘧啶。它在每次产前护理就诊时每月计划一次,最多持续 36 周。在这里,我们试图评估 Webuye 医院疟疾孕妇中间歇性预防治疗的知识、态度和实践。
本研究共纳入 140 名年龄在 18 至 49 岁之间、妊娠约 16 周的参与者,采用定性定量混合方法。在入组前,使用显微镜进行疟疾检测,参与者分为两组:疟疾阳性组和疟疾阴性组。使用封闭式和开放式问卷。进行定性定量数据分析。
我们的分析表明,在对副作用(p≤0.001)和不同剂量(p≤0.012)的间歇性预防治疗的知识方面,阴性和阳性组母亲的比例存在显著差异。与阴性组相比,疟疾阳性组中知道副作用和不同剂量的母亲比例更高,分别为 37(52.9%,n=70)对 18(25.7%,n=70)和 14(20.0%,n=70)对 4(5.7%,n=70)。此外,两组在给药前关于间歇性预防治疗的知识也存在显著差异(p≤0.003)。
应该利用关于间歇性预防治疗(IPT)益处、副作用、安全性、剂量和其他事先信息的良好知识、态度和实践,赋予疟疾流行地区的孕妇权力。